Haiyang Yu | Pharmaceutical Science | Best Researcher Award

Prof. Haiyang Yu | Pharmaceutical Science | Best Researcher Award

Professor at Tianjin University of Traditional Chinese Medicine, China

Professor Haiyang Yu is an accomplished researcher and academic in the field of pharmacology and traditional Chinese medicine. With a focus on the anti-tumor molecular mechanisms of natural products, he has significantly contributed to cancer research. His work delves into understanding how small molecules in traditional Chinese medicine and other natural sources can target cancerous cells. Throughout his career, Professor Yu has gained recognition for his work, publishing over 40 peer-reviewed articles, including in prestigious journals such as Nature Communications and the Journal of Hematology & Oncology. He has also led six national research projects. His lab at Tianjin University of Traditional Chinese Medicine explores the pharmacological potential of these compounds, using network pharmacology to identify new drug targets and elucidate the molecular mechanisms behind anti-tumor effects. His research has the potential to transform cancer treatment by merging the ancient wisdom of TCM with modern scientific methods.

Professional Profile

Education

Professor Haiyang Yu holds a Ph.D. from Dong-a University, where he honed his academic foundation in pharmacology and molecular biology. After earning his doctoral degree, he pursued postdoctoral research training from 2012 to 2014, furthering his expertise in the molecular mechanisms of disease and drug discovery. This rigorous academic journey provided him with the necessary skills to embark on significant research in cancer pharmacology. His educational background underscores his commitment to advancing scientific knowledge, particularly in integrating traditional medicine with modern pharmacological practices. Professor Yu’s academic credentials have shaped him into a leader in his field, allowing him to explore novel therapeutic pathways for cancer treatment through natural products and traditional Chinese medicine.

Professional Experience

Currently serving as a professor at Tianjin University of Traditional Chinese Medicine, Professor Haiyang Yu has built a distinguished career. His position allows him to influence the next generation of researchers while continuing his own innovative work. His research is primarily concerned with the anti-tumor effects of natural products, an area in which he has published extensively. He has presided over six national projects, demonstrating his leadership capabilities and ability to secure funding for significant research initiatives. Prior to this, Professor Yu gained invaluable postdoctoral experience, expanding his research scope and applying his findings in practical settings. His experience includes collaborations with international researchers, which further enhances his ability to contribute to the global understanding of cancer pharmacology. Throughout his career, Professor Yu has successfully blended traditional Chinese medicine and contemporary research techniques, achieving breakthroughs that have had an impact on both scientific and medical communities.

Research Interests

Professor Haiyang Yu’s research primarily focuses on network pharmacology, natural products, traditional Chinese medicine (TCM), and cancer drug discovery. His interest lies in uncovering the molecular mechanisms by which natural compounds, especially those derived from TCM, exhibit anti-cancer properties. By employing advanced techniques in network pharmacology, Professor Yu investigates how these compounds interact with specific drug targets to inhibit cancer cell growth. His lab’s research aims to explore novel drug targets that could lead to more effective cancer therapies. A key part of his research involves exploring the synergy between traditional Chinese medicine and modern pharmacological methods, bridging ancient knowledge with cutting-edge technology. This interdisciplinary approach is central to his work, providing new avenues for the development of cancer treatments and potentially improving the effectiveness of existing therapies.

Research Skills

Professor Haiyang Yu’s research skills encompass a broad array of advanced techniques in pharmacology, molecular biology, and bioinformatics. His expertise in network pharmacology enables him to explore the complex interactions between small molecules and drug targets, a crucial area for drug discovery. Additionally, his proficiency in cell biology and molecular biology techniques, such as cell culture, gene expression analysis, and protein assays, allows him to delve deep into the cellular mechanisms underlying cancer progression. Professor Yu’s lab also employs cutting-edge computational tools to predict drug-target interactions and evaluate the therapeutic potential of natural compounds. Furthermore, his extensive experience with bioinformatics allows for the integration of large-scale biological data, which is essential for identifying potential therapeutic pathways and developing novel cancer drugs. His skills in both experimental and computational research make him a leading figure in his field.

Awards and Honors

Professor Haiyang Yu has received numerous accolades for his groundbreaking contributions to cancer research and traditional Chinese medicine. He has been recognized for his leadership in national research projects, successfully leading six such initiatives that have received considerable funding. His outstanding scholarly work has earned him a reputation as a leading expert in his field, culminating in invitations to present at international conferences and contribute to high-impact journals. His publication record, which includes over 40 papers in prestigious journals such as Nature Communications and the Journal of Hematology & Oncology, underscores his standing within the scientific community. These honors not only reflect his individual achievements but also highlight his capacity to drive scientific innovation in pharmacology and oncology. Professor Yu’s ongoing contributions continue to shape the direction of research in cancer therapies and natural product pharmacology.

Conclusion

Professor Haiyang Yu is an exceptional candidate for recognition as a Best Researcher. With a solid educational background, extensive professional experience, and a significant body of research publications, he has established himself as a leader in the field of cancer research and traditional Chinese medicine. His work in identifying novel anti-tumor mechanisms through natural products and network pharmacology has the potential to revolutionize cancer therapy. His leadership in national research projects, combined with his innovative research methods, has led to significant advancements in the understanding of cancer and drug discovery. As an academic and researcher, Professor Yu continues to push the boundaries of pharmacology, integrating traditional wisdom with modern scientific methodologies. His achievements reflect both personal excellence and a broader commitment to the advancement of cancer research, making him a deserving candidate for the Best Researcher Award.

Publication Top Notes

  1. Title: Autocrine and paracrine LIF signals to collaborate sorafenib-resistance in hepatocellular carcinoma and effects of Kanglaite Injection
    Authors: Shao, Y., Pu, W., Su, R., Han, L., Yu, H.
    Year: 2025
  2. Title: Intestinal FXR deficiency induces dysregulation of xanthine oxidase and accounts for sex difference in hyperuricemia
    Authors: Bao, R., Chen, B., Wang, A., Zhang, Y., Wang, T.
    Year: 2025
  3. Title: Immunometabolism in cancer: basic mechanisms and new targeting strategy
    Authors: Su, R., Shao, Y., Huang, M., Yu, H., Qiu, Y.
    Year: 2024
    Citations: 4
  4. Title: Arnicolide D induces endoplasmic reticulum stress-mediated oncosis via ATF4 and CHOP in hepatocellular carcinoma cells
    Authors: Lin, Y.-S., Sun, Z., Shen, L.-S., Chen, S., Chen, G.-Q.
    Year: 2024
    Citations: 6
  5. Title: Babaodan inhibits cell proliferation and metastasis and enhances anti-tumor effects of camrelizumab by inhibiting M2 phenotype macrophages in hepatocellular carcinoma
    Authors: Liu, C., Lin, X., Huang, M., Qiu, Y., Yu, H.
    Year: 2024
    Citations: 2
  6. Title: Energy Landscape Reveals the Underlying Mechanism of Cancer-Adipose Conversion in Gene Network Models
    Authors: Chen, Z., Lu, J., Zhao, X.-M., Yu, H., Li, C.
    Year: 2024
  7. Title: Repurposing cyclovirobuxine D as a novel inhibitor of colorectal cancer progression via modulating the CCT3/YAP axis
    Authors: Liu, Y., Chen, L., Wang, J., Wang, T., Yu, H.
    Year: 2024
  8. Title: The role of NCAPH in cancer treatment
    Authors: Liu, C., Han, X., Zhang, S., Pu, W., Yu, H.
    Year: 2024
  9. Title: Dan-shen Yin promotes bile acid metabolism and excretion to prevent atherosclerosis via activating FXR/BSEP signaling pathway
    Authors: Sheng, Y., Meng, G., Zhang, M., Wang, Y., Jiang, M.
    Year: 2024
    Citations: 2
  10. Title: Natural products with anti-tumorigenesis potential targeting macrophage
    Authors: Liu, H., Huang, M., Xin, D., Yu, H., Pu, W.
    Year: 2024

 

Yanan Jiang | Pharmaceutical Science | Best Researcher Award

Prof. Yanan Jiang | Pharmaceutical Science | Best Researcher Award

Professor at Harbin Medical University, China

Dr. Yanan Jiang is a Professor at Harbin Medical University, where she has been actively contributing to the field of pharmacology through impactful research and academic leadership. Her work primarily focuses on understanding the mechanisms of arsenic trioxide, therapeutic targets for cardiac injury, and the bioinformatics analysis of tumor and cardiovascular disease targets. With a robust academic foundation and over 26 SCI-indexed publications as the first or corresponding author, Dr. Jiang has established herself as a multidisciplinary researcher. She has secured funding for eight research projects, including prestigious grants from the National Natural Science Foundation of China. Additionally, Dr. Jiang serves on the editorial board of Scientific Reports and as a guest editor for four SCI journals. Her career reflects a balance of research innovation, academic excellence, and leadership in the global scientific community.

Professional Profile

Education

Dr. Jiang holds a Ph.D. in Pharmacology from Harbin Medical University, which she completed in December 2016. Her doctoral research laid the foundation for her current focus on molecular mechanisms in pharmacology and bioinformatics. Prior to this, she earned a Bachelor of Science in Traditional Chinese Medicine from the same university in 2010. This dual educational background integrates modern pharmacological techniques with traditional Chinese medicinal principles, enabling her to adopt a unique and comprehensive approach in her research. Her academic credentials highlight a commitment to understanding and innovating within pharmacological sciences.

Professional Experience

Dr. Jiang began her academic career as a Lecturer at Harbin Medical University in 2017. She was later promoted to Associate Professor, a role she held from 2017 to 2023, during which she also pursued a postdoctoral fellowship focusing on bioinformatics. Her postdoctoral research enhanced her expertise in utilizing computational approaches to study tumor and cardiovascular disease mechanisms. In September 2023, Dr. Jiang was appointed Professor at Harbin Medical University, a position that underscores her leadership and research excellence. Over the years, she has played a pivotal role in advancing pharmacology and bioinformatics, reflecting her versatility and dedication to interdisciplinary research.

Research Interests

Dr. Jiang’s research interests center around pharmacology, particularly the mechanisms and therapeutic applications of arsenic trioxide. She investigates the molecular pathways of cardiac injury and explores potential therapeutic targets to mitigate its impact. Additionally, she applies bioinformatics to analyze tumor and cardiovascular disease mechanisms, identifying novel biomarkers and therapeutic targets. Her multidisciplinary approach bridges traditional pharmacology and cutting-edge computational techniques, enabling the development of innovative treatment strategies. Dr. Jiang’s research not only contributes to the fundamental understanding of disease mechanisms but also holds significant translational potential for clinical applications.

Research Skills

Dr. Jiang possesses a diverse skill set that includes molecular pharmacology, bioinformatics, and experimental design for preclinical studies. Her expertise extends to the computational analysis of large datasets to identify disease biomarkers and therapeutic targets. She is proficient in leading complex, multi-institutional research projects, as evidenced by her role as principal investigator for eight funded studies. Her ability to integrate experimental and computational methods enhances her capability to tackle multifaceted scientific questions. Furthermore, Dr. Jiang’s editorial experience with renowned journals equips her with advanced skills in peer review, scientific communication, and publication management.

Awards and Honors

Dr. Jiang has been the recipient of multiple prestigious awards and honors that reflect her academic and research excellence. She has been awarded competitive grants, including those from the National Natural Science Foundation of China and the China Postdoctoral Science Foundation, highlighting her ability to attract substantial research funding. Her editorial roles with Scientific Reports and other SCI-indexed journals underscore her recognition as a leading expert in her field. These accolades, combined with her promotion to Professor at a young age, illustrate her significant contributions to pharmacology and bioinformatics, positioning her as a distinguished researcher in the scientific community.

Conclusion

Dr. Yanan Jiang is a highly competitive candidate for the Best Researcher Award, given her strong academic trajectory, robust research output, and success in securing funding. Her multidisciplinary expertise in pharmacology and bioinformatics, combined with her leadership roles in journals, underlines her prominence in her field. To further solidify her candidacy, she could emphasize her international collaborations, citation metrics, and mentorship contributions. Nonetheless, her accomplishments and expertise align well with the criteria for this award, making her a worthy contender.

Publication Top Notes

  1. Intestinal microbiota homeostasis analysis in riboflavin-treated alcoholic liver disease
    Authors: Shen, X., Shi, C., Xu, J., … Jiang, Y., Sun, H.
    Year: 2024
  2. Comprehensive characterization of long QT syndrome-associated genes in cancer and development of a robust prognosis model
    Authors: Xu, J., Wen, Z., She, Y., … Wang, S., Jiang, Y.
    Year: 2024
  3. Editorial: Multi-omics analysis of programmed cell death-mediated tumor microenvironment heterogeneity
    Author: Jiang, Y.
    Year: 2024
  4. An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications
    Authors: Jiang, Y., Shen, X., Zhi, F., … Yang, B., Bai, Y.
    Year: 2023
    Citations: 15
  5. Correction: The involvement and therapeutic potential of lncRNA Kcnq1ot1/miR-34a-5p/Sirt1 pathway in arsenic trioxide-induced cardiotoxicity
    Authors: Shen, X., Zhi, F., Shi, C., … Bai, Y., Yang, B.
    Year: 2023
    Citations: 1
  6. The involvement and therapeutic potential of lncRNA Kcnq1ot1/miR-34a-5p/Sirt1 pathway in arsenic trioxide-induced cardiotoxicity
    Authors: Shen, X., Zhi, F., Shi, C., … Jiang, Y., Yang, B.
    Year: 2023
    Citations: 10
  7. Open a new epoch of arsenic trioxide investigation: ATOdb
    Authors: Jiang, Y., Li, J., Liu, Y., … Shao, T., Xu, Y.
    Year: 2023
  8. Characterization of the metabolic alteration-modulated tumor microenvironment mediated by TP53 mutation and hypoxia
    Authors: Luo, K., Qian, Z., Jiang, Y., … Jin, S., Shang, D.
    Year: 2023
    Citations: 16
  9. From Phenomenon to Essence: A Newly Involved lncRNA Kcnq1ot1 Protective Mechanism of Bone Marrow Mesenchymal Stromal Cells in Liver Cirrhosis
    Authors: Zhangdi, H., Jiang, Y., Gao, Y., … Geng, X., Jin, S.
    Year: 2023
    Citations: 2
  10. Research Progress of New Dosage Forms of Arsenic Trioxide | 三氧化二砷新剂型的研究进展
    Authors: Liao, R., Shi, C., Fu, W., … Zhi, F., Jiang, Y.
    Year: 2023
    Citations: 1

 

 

 

Sujatha Kuppusamy | Microbiology | Best Researcher Award

Sujatha Kuppusamy | Microbiology | Best Researcher Award

Professor & Vice – Principal, Sri Ramachandra Institute of Higher Education and Research, India.

Dr. K. Sujatha Kuppusamy is a renowned Professor in the Department of Pharmaceutical Chemistry at Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (DU) in Chennai, India. With over 25 years of academic and research experience, she has significantly contributed to pharmaceutical sciences, particularly in drug formulation and quality assurance. Dr. Sujatha holds a Ph.D. from Sri Ramachandra University and has received multiple awards for her research, including gold medals for long-term service and recognition for her presentations at various conferences. Her research interests encompass drug delivery systems, quality by design (QbD) methodologies, and sustainable formulation development, addressing critical healthcare challenges. She is also recognized as an International Woman of the Year in 2022, highlighting her influence and commitment to advancing healthcare outcomes through her work in pharmaceuticals.

Profile:

Scopus Profile

ORCID

Education

Dr. K. Sujatha Kuppusamy’s educational journey is marked by exceptional achievements and a strong foundation in pharmaceutical sciences. She completed her Ph.D. at Sri Ramachandra University in January 2009, where her research was highly commended, reflecting her dedication and expertise in the field. Prior to her doctoral studies, she earned her Master of Pharmacy (M.Pharm) in Pharmaceutical Chemistry in March 1997 from The T.N. Dr. MGR Medical University, graduating with first-class honors. Dr. Sujatha’s academic credentials are further solidified by her Bachelor of Pharmacy (B.Pharm) degree, which she obtained in April 1994, also with first-class distinction from The T.N. Dr. MGR Medical University. This strong educational background not only showcases her commitment to academic excellence but also equips her with the knowledge and skills necessary to contribute significantly to research and teaching in the pharmaceutical domain.

Professional Experience

Dr. K. Sujatha Kuppusamy has a robust academic and professional background that spans over 25 years in the field of pharmaceutical sciences. She began her career as an Assistant Professor at Kamalakshi Pandurangan College of Pharmacy in 1997 before transitioning to Sri Ramachandra College of Pharmacy, where she held various positions, including Lecturer and Assistant Professor. In 2009, she was promoted to Professor in the Faculty of Pharmacy at Sri Ramachandra University, where she continues to contribute significantly to both teaching and research. Throughout her career, Dr. Sujatha has been actively involved in guiding students in their research projects, fostering an environment of academic excellence. Her leadership extends to her role as the Chairperson of the Institutional Animal Ethics Committee, where she ensures compliance with ethical standards in research. Dr. Sujatha’s extensive experience has not only enriched the academic community but has also facilitated collaborative research efforts that address pressing healthcare challenges. Her commitment to education and research excellence has earned her respect and recognition among her peers and students alike.

Research Interests

Dr. K. Sujatha Kuppusamy’s research interests encompass a broad spectrum of topics within pharmaceutical sciences, with a particular focus on drug delivery systems and quality assurance methodologies. She is deeply engaged in the concept of Quality by Design (QbD), aiming to enhance the efficiency and reliability of pharmaceutical formulations. Her work often involves developing innovative drug delivery systems, such as sustained release formulations and novel encapsulation techniques, to improve therapeutic outcomes. Additionally, Dr. Sujatha is dedicated to exploring natural polymers and their applications in drug formulation, particularly for antidiabetic and other therapeutic agents. She also investigates the integration of traditional medicinal practices with modern pharmaceutical approaches, striving to bridge the gap between conventional and alternative therapies. Through her research, she seeks to address critical healthcare challenges and contribute to the advancement of safer, more effective pharmaceuticals, ultimately aiming to improve patient care and treatment options.

Award and Recognition

Dr. K. Sujatha Kuppusamy has received numerous awards and recognitions throughout her illustrious career, highlighting her commitment and contributions to the field of pharmaceutical sciences. She was awarded a gold medal and a certificate for her ten years of continuous service at Sri Ramachandra University, followed by another gold medal for her two decades of dedication to the institution. Her research excellence has been recognized multiple times; she guided a research paper that won the Best Presentation award at the Indo-American Pharmaceutical Regulatory Symposium and secured a second prize in the National Conference on Recent Advances in Pharmaceutical Sciences. Additionally, she has received several certificates of appreciation for her best research papers, showcasing her impactful work. Dr. Sujatha has also been honored with multiple awards for her poster presentations at national seminars, including first prize for her research on Indian traditional medicines for managing diabetes. Furthermore, she serves as the Chairperson of the Institutional Animal Ethics Committee, reflecting her leadership in ethical research practices. Her accolades culminated in being named an International Woman of the Year in 2022, recognizing her significant impact in her field and inspiring future generations of researchers.

 

Publication Top Notes

      1. QbD-Based Stability-Indicating RP-HPLC Method Development and Validation for the Estimation of Favipiravir—An Eco-Friendly Approach
        Authors: Siri Chandana, M., Sujatha, K., Ajitha, A., Narendra, P., Sonia, K.
        Year: 2024
        Citation: Journal of AOAC International, 107(3), pp. 377–386. 🧪🌱
      2. An Overview of Pharmacological Activities and Beneficial Effects of 3-Hydroxyflavone
        Authors: Ayyanna, C., Kuppusamy, S., Kumar, P.P.
        Year: 2024
        Citation: Macromolecular Symposia, 413(2), 2300078. 📚💊
      3. Analytical Quality by Design-Assisted HPLC Method for Quantification of Canagliflozin and Stability Studies
        Authors: Azhakesan, A., Kuppusamy, S.
        Year: 2023
        Citation: ACS Omega, 8(8), pp. 7407–7414. 🔍📈
      4. Development and Validation of UFLC-MS/MS Analytical Method for the Simultaneous Quantification of Antibiotic Residues in Surface Water, Groundwater, and Pharmaceutical Waste Water Samples from South India
        Authors: Kamatham, S., Seeralan, M., Sekar, U., Kuppusamy, S.
        Year: 2023
        Citation: ACS Omega. 🌊💧
      5. QbD-Based Development and Validation of Novel Stability-Indicating Method for the Assay and Dissolution of Garenoxacin in Garenoxacin Tablets
        Authors: Azhakesan, A., Kuppusamy, S.
        Year: 2022
        Citation: Journal of AOAC International, 105(2), pp. 370–378. 📦💊
      6. Canagliflozin: A review with specific focus on analytical methods in biological matrices and pharmaceuticals
        Authors: Azhakesan, A., Kuppusamy, S.
        Year: 2022
        Citation: Reviews in Analytical Chemistry, 41(1), pp. 287–300. 🧬📖
      7. Formulation and Evaluation of Miglitol Matrix Tablets by Using Hibiscus Rosa Sinensis Leaves Mucilage
        Authors: Deepika, B., Sujatha, K., Thanga Thirupathi, A., Chamundeeswari, D.
        Year: 2021
        Citation: Research Journal of Pharmacy and Technology, 14(1), pp. 245–248. 🌺💊
      8. Bioanalytical Method Development and Validation for Simultaneous Estimation of Nitazoxanide and Ofloxacin in Human Plasma by RP-HPLC
        Authors: Ajitha, A., Abbulu, K., Sujatha, K., Sireesha, P.
        Year: 2020
        Citation: Indian Drugs, 57(10), pp. 47–57. 💉🔬
      9. Bioanalytical Method Development and Validation of Garenoxacin Mesylate in Human Plasma by RP-HPLC
        Authors: Ajitha, A., Sujatha, K., Abbulu, K.
        Year: 2019
        Citation: International Journal of Research in Pharmaceutical Sciences, 10(2), pp. 1314–1320. 🧪🩸
      10. The Identification of Bioactive Compounds from Turbinaria Ornata (Turner) J. Agaradh and Computational Studies
        Authors: Deepa, S., Sujatha, K., Velmurugan, D.
        Year: 2019
        Citation: Pharmacognosy Journal, 11(5), pp. 873–883. 🍃🔍

Mary Nyakato | social sciences | Best Researcher Award

Mary Nyakato | social sciences | Best Researcher Award

Doctoral student, Makerere University, Uganda

Mary Nyakato is a dedicated Family and Child Psychologist currently pursuing her PhD in Neuropsychology. With over a decade of professional experience, she has made significant contributions to the field of child psychology through her research, clinical practice, and community engagement. Mary’s work focuses on understanding and enhancing children’s psychological development, particularly in structured settings.

Profile:

Scopus Profile

Education

Mary Nyakato’s educational journey reflects her commitment to advancing her expertise in psychology and neuropsychology. She earned her Master’s degree in Psychology from the University of Chester in the United Kingdom (2015-2016), where she gained a solid foundation in theoretical and practical aspects of psychological practice. Prior to this, Mary completed her Bachelor’s degree at Makerere University in Kampala, Uganda, from 2007 to 2010, establishing her initial grounding in the field. Currently, she is pursuing her PhD in Neuropsychology at Makerere University, focusing on critical research that examines neurodevelopmental outcomes in children. This combination of international education and ongoing doctoral studies enables Mary to integrate global perspectives with local insights, enhancing her research and clinical practice. Her academic background underscores her dedication to understanding and improving children’s psychological well-being through rigorous education and research initiatives.

Professional Experience

Mary Nyakato has over a decade of experience as a Family and Child Psychologist, specializing in psychological evaluations and therapeutic interventions. Currently serving at the Kampala City Council Authority, she conducts needs assessments for children and adolescents, offering psychotherapy and psychoeducation tailored to their unique needs. Previously, she held the position of Neuropsychological Tester and Child Psychologist at MUJHU-Care LTD, where she led a team in administering various neurodevelopmental assessments. Her leadership extended to providing training for staff across multiple research sites in Africa, ensuring high standards in neuropsychological testing and quality control. Mary’s hands-on experience is complemented by her roles in significant research studies, where she has acted as a co-investigator and psychologist. Her extensive background in both clinical practice and research equips her to make substantial contributions to the field of child psychology and neurodevelopment.

Research Interests

Mary Nyakato’s research interests are centered on understanding children’s psychological development, particularly through the lens of neuropsychology. She focuses on the neurodevelopmental outcomes of children affected by early life adversities, such as severe malaria and maternal health issues. Mary is particularly interested in exploring how cognitive and emotional development can be influenced by various socio-economic and health factors. Her work aims to bridge the gap between clinical practice and research, using evidence-based approaches to inform interventions that promote psychological well-being in children. Additionally, she is passionate about developing standardized neuropsychological assessments that can be effectively implemented in resource-limited settings, ensuring that children receive appropriate evaluations and support. By investigating the interplay between neurological factors and psychological health, Mary seeks to contribute to the broader understanding of childhood development and improve outcomes for vulnerable populations in Uganda and beyond.

Award and Recognition

Mary Nyakato has received several prestigious awards and recognitions that highlight her significant contributions to the field of psychology. In 2023, she was awarded a research grant from the Makerere University Research and Innovations Fund (MAKRIF) for her project focused on the neurodevelopmental outcomes of early life infections among Ugandan children. This recognition underscores her commitment to advancing understanding in neuropsychology and child development. Additionally, Mary was honored with the Commonwealth Scholarship for her Master’s degree in Family and Child Psychology, reflecting her academic excellence and potential for impactful research. Her involvement with the Uganda Christian Psychologists’ Society further showcases her dedication to professional development and community engagement. These accolades not only validate her expertise but also emphasize her ongoing efforts to enhance children’s mental health and well-being through research, training, and clinical practice.

 

Publication Top Notes

  • Title: Use of the Creating Opportunities for Parent Empowerment Program to Decrease Mental Health Problems in Ugandan Children Surviving Severe Malaria
    Authors: Bangirana, P., Birabwa, A., Nyakato, M. et al.
    Year: 2021
    Citation: Malaria Journal, 20, 267. https://doi.org/10.1186/s12936-021-03795-y
    Emojis: 🌍🧠👶
  • Title: Neurodevelopmental Effects of Ante-partum and Post-partum Antiretroviral Exposure in HIV-Exposed and Uninfected Children Versus HIV-Unexposed and Uninfected Children in Uganda and Malawi: A Prospective Cohort Study
    Authors: Boivin, M., Maliwichi-Senganimalunje, L., Ogwang, W.L., Kawalazira, R., Sikorskii, A., Familiar-Lopez, I., Kuteesa, A., Nyakato, M., Mutebe, A., Namukooli, J.L., Mallewa, M., Ruiseñor-Escudero, H., Aizire, J., Taha, E.T., & Fowler, M.G.
    Year: 2019
    Citation: The Lancet HIV.
    Emojis: 💊👶🌈
  • Title: Building Capacity in Neurodevelopment Assessment of Children in Sub-Saharan Africa: A Quality Assurance Model to Implement Standardized Neurodevelopment Testing
    Authors: Ruiseñor-Escudero, H., Familiar, I., Nyakato, M., Kutessa, A., Namukooli, J., Ssesanga, T., Joyce, C., Laughton, B., Grab, J., Chernoff, M., Vhembo, T., Fairlie, L., Kamthunzi, P., Boivin, M & the IMPAACT P1104s Team
    Year: 2018
    Citation: Child Neuropsychology, Journal on Normal and Abnormal Development in Childhood and Adolescence, 1-16.
    Emojis: 📚🧠🌍
  • Title: Neurodevelopment of Ugandan and Malawian PROMISE Exposed and Unexposed Uninfected Children at 12 and 24 Months of Age
    Authors: Boivin, M.J., Malawichi-Senganimalunje, L., Nyakato, M., Sikorski, A., Ogwang, L.W., Kawalazira, R., Mallewa, M., Familiar-Lopez, I., Horacio, E., Aizire, J., Taha, T., & Fowler, M.G.
    Year: 2016
    Citation: Conference paper presented at the International AIDS Society Meeting, Durban, RSA.
    Emojis: 🎓👶🇿🇦

Elena Kazali | Psychology | Best Researcher Award

Elena Kazali | Psychology | Best Researcher Award

Assistant Professor on tenure track of Cognitive-Experimental Psychology Department of Psychology, University of Ioannina, Greece

Elena Kazali is an accomplished Assistant Professor in Cognitive-Experimental Psychology at the University of Ioannina. With a strong emphasis on cognitive development and educational psychology, she combines academic rigor with a commitment to practical applications in educational settings. Her research explores the intricacies of cognitive processes, particularly in children, making significant contributions to understanding developmental psychology.

Profile:

Scopus Profile

Education

Elena earned her Doctor of Philosophy in Cognitive Development-Educational Psychology from Panteion University, achieving a “Distinction.” She also holds a Master’s Degree in Developmental Psychology from Lancaster University and a Bachelor’s degree in Psychology from Panteion University. This robust educational background has equipped her with the theoretical and practical knowledge necessary for her academic and research endeavors.

Professional Experience

Elena has extensive teaching experience at both undergraduate and postgraduate levels across several universities. She has contributed significantly to educational programs in psychology and special education, focusing on developmental psychology. Her roles include adjunct lecturer and tutor in various e-learning programs, demonstrating her versatility and dedication to student learning.

Research Interests

Elena’s research interests lie in cognitive development, language processing, and metacognition, particularly in preschool and school-aged children. She investigates how these cognitive processes influence educational outcomes and social adaptation, aiming to improve educational strategies for children with developmental challenges. Her work seeks to bridge theoretical research with practical applications in educational settings.

Award and Recognition

Elena received the Best Doctoral Thesis Award “Maria Nasiakou” from the Hellenic Psychological Society for her outstanding doctoral research. This recognition underscores her commitment to excellence in psychological research. Additionally, her participation in numerous national and international conferences showcases her dedication to advancing the field of psychology and her engagement with the academic community.

Publication Top Notes

  • Understanding the developmental needs of children with developmental language disorder according to professionals
    Authors: Ralli, A.M., Kalliontzi, E., Kazali, E., Palikara, O.
    Year: 2023
    Citation: In Childhood Developmental Language Disorders: Role of Inclusion, Families, and Professionals, pp. 159–174. 📚👶
  • Cognitive and linguistic factors in autism spectrum disorders
    Authors: Kazali, E., Koutsimani, P.
    Year: 2023
    Citation: In Developmental Language Disorders in Childhood and Adolescence, pp. 85–100. 🧠📖
  • Teachers’ Views of Children With Developmental Language Disorder in Greek Mainstream Schools
    Authors: Ralli, A.M., Kalliontzi, E., Kazali, E.
    Year: 2022
    Citation: Frontiers in Education, 7, 832240. 🌍🏫
  • Oral Language and Story Retelling During Preschool and Primary School Years: Developmental Patterns and Interrelationships
    Authors: Ralli, A.M., Kazali, E., Kanellou, M., et al.
    Year: 2021
    Citation: Journal of Psycholinguistic Research, 50(5), pp. 949–965. 📖✨
  • Oral language skills and psychosocial competence in early school-aged children of different language profiles
    Authors: Ralli, A.M., Kazali, E., Karatza, E.
    Year: 2021
    Citation: Psychology, 26(1), pp. 40–55. 🗣️👦👧
  • Cognition and cognizance in preschool predict school achievement in primary school
    Authors: Demetriou, A., Kazali, E., Kazi, S., Spanoudis, G.
    Year: 2020
    Citation: Cognitive Development, 54, 100872. 📊🏆
  • Cognizance in cognitive development: A longitudinal study
    Authors: Kazi, S., Kazali, E., Makris, N., Spanoudis, G., Demetriou, A.
    Year: 2019
    Citation: Cognitive Development, 52, 100805. 🔍📅
  • Mapping the Dimensions of General Intelligence: An Integrated Differential-Developmental Theory
    Authors: Demetriou, A., Makris, N., Spanoudis, G., et al., Kazali, E.
    Year: 2018
    Citation: Human Development, 61(1), pp. 4–42. 🌐🧩
  • Developmental differentiation and binding of mental processes with g through the life-span
    Authors: Demetriou, A., Spanoudis, G., Kazi, S., et al., Kazali, E.
    Year: 2017
    Citation: Journal of Intelligence, 5(2), pp. 1–31. 🧠🔗

Shruti Prajapati | electrical | Excellence in Research

Shruti Prajapati | electrical | Excellence in Research

Research Scholar, Delhi Technological University, India.

Shruti Prajapati is a dynamic researcher specializing in control techniques for renewable energy systems and power converters. Her expertise spans microgrids, solar photovoltaic systems, artificial neural networks, and optimization methods. Currently pursuing her Ph.D. at Delhi Technological University, she has made significant strides in energy management and innovative power control solutions. Prajapati’s research focuses on improving the efficiency and reliability of renewable energy resources, evidenced by her contributions to top-tier journals and conferences. Her work demonstrates a commitment to advancing sustainable energy technologies through innovation and practical applications.

Profile:

Scopus Profile

Education

Shruti Prajapati holds an M.Tech in Power Systems and Control from Birla Institute of Technology, Mesra, achieving an impressive 82.9%. She also completed her B.E. in Electrical & Electronics Engineering from M.S. Engineering College, Bangalore, with a score of 71.5%. Currently, she is pursuing her Ph.D. at Delhi Technological University. Her strong academic background is complemented by her skills in MATLAB, energy modeling, and control techniques for renewable energy systems.

Professional Experience

Prajapati has garnered experience in research and academic settings, particularly focusing on renewable energy systems and power electronics. Her skills in energy management, control techniques for solar PV and battery systems, and energy modeling have equipped her to handle complex challenges in microgrid systems. Her hands-on experience includes coding in MATLAB Simulink and control optimization techniques, which she has applied in both academic and industry-related projects. Her work integrates cutting-edge technologies with practical applications.

Research Interests

Prajapati’s research interests revolve around renewable energy resources, with a strong focus on microgrids, power converters, and optimization techniques. She is also deeply involved in exploring artificial neural networks and islanding detection methods in renewable systems. Her aim is to enhance the control and stability of energy systems, contributing to the field through advanced algorithms and control strategies for hybrid standalone microgrids and grid-integrated solar PV systems.

Award and Recognition

Shruti Prajapati has published in high-impact SCIE journals, including Electric Power Systems Research and Computers and Electrical Engineering. Her notable achievements include a Q1 category publication and several papers on control techniques for solar photovoltaic systems. In 2024, she co-authored a book chapter on network reconfiguration-based outage management. Additionally, she has presented her research at international conferences like the IEEE International Conference on Contemporary Computing and Informatics, further establishing her credentials in renewable energy research.

 

Publication Top Notes

  • Modified Control Approach for MPP Tracking and DC Bus Voltage Regulation in a Hybrid Standalone Microgrid
    • Author: Shruti Prajapati, R. Garg, P. Mahajan
    • Year: 2024
    • Citation: Electric Power Systems Research, 236, p.110935. 🔌⚡️
  • Novel Adaptive MPPT Technique for Enhanced Performance of Grid Integrated Solar Photovoltaic System
    • Author: Shruti Prajapati, R. Garg, P. Mahajan
    • Year: 2024
    • Citation: Computers and Electrical Engineering. (Accepted) ☀️🔋
  • Honey Badger Algorithm Based PI Controller for DC Link Voltage Control of Solar Photovoltaic System Connected to Grid for Enhanced Power Quality
    • Author: Shruti Prajapati, R. Garg, P. Mahajan
    • Year: 2024
    • Citation: Electric Power Components and Systems, pp.1-20. 📈🔧
  • Network Reconfiguration-Based Outage Management for Reliability Enhancement of Microgrid: A Hardware in Loop Approach
    • Author: Shruti Prajapati, S.K. Sahu, D. Ghosh
    • Year: 2024
    • Citation: In The Internet of Energy, pp. 337-357. 📡🌐
  • Evolutionary Algorithm for Enhanced Performance of Grid Connected SPV System
    • Author: Shruti Prajapati, R. Garg, P. Mahajan
    • Year: 2022
    • Citation: In 2022 5th International Conference on Contemporary Computing and Informatics (IC3I), pp. 814-820. 🌞🛠️

Sampatha Goonewardena| Cancer palliative care | Best Researcher Award

Sampatha Goonewardena| Cancer palliative care | Best Researcher Award

Professor in Community Medicine, University of Sri Jayewardenepura, Sri Lanka

Professor Christine Sampatha Evangeline Goonewardena is an accomplished academic and medical professional specializing in Community Medicine. With a career spanning over three decades, she has made substantial contributions to public health, particularly in maternal and child health, reproductive health, and public health education. As a professor at the University of Sri Jayewardenepura in Sri Lanka, she has led numerous research projects that have influenced health policies and improved community-level healthcare practices. Her work has garnered several national and international awards, underscoring her impact in public health. In addition to her research, she has held leadership positions and contributed to academic development through teaching and mentoring young researchers. Her publications, both individually and in collaboration, have addressed critical public health challenges and brought her widespread recognition in Sri Lanka and beyond. Professor Goonewardena’s dedication to improving healthcare outcomes reflects her commitment to academic excellence and community well-being.

Profile:

Scopus Profile

Education

Professor Goonewardena has an extensive educational background in medicine and public health. She earned her MBBS from North Colombo Medical College in Sri Lanka in 1990, laying the foundation for her medical career. She later pursued an MSc in Community Medicine from the Post Graduate Institute of Medicine, University of Colombo, in 1994, which included in-depth research on breastfeeding practices in urban slums. Her commitment to advancing community health led her to complete her MD in Community Medicine from the same institution in 2001, with a thesis focused on intrapartum and postpartum care in primary care settings. In 2003, she further specialized by obtaining a Diploma in Reproductive Health from the Liverpool School of Tropical Medicine, UK. This diverse academic background, combining clinical and public health expertise, has equipped her to address key health issues at both national and international levels.

Professional Experience

Professor Goonewardena has held various pivotal roles throughout her career in academia and public health. Currently, she serves as a Professor of Community Medicine at the Faculty of Medical Sciences, University of Sri Jayewardenepura, a position she has held since 2017. Before this, she served as a Senior Lecturer in the same department from 2002 to 2017, demonstrating her deep commitment to teaching and research. She also led the Department of Community Medicine as Head from 2006 to 2009 and again from 2012 to 2014. Earlier in her career, she worked as a Medical Officer specializing in Maternal and Child Health in the Colombo Municipality from 1991 to 1996. Her extensive work experience includes both clinical practice and academic roles, allowing her to bridge the gap between research and practical health solutions. She also serves as a Specialist Community Physician in the University Field Health Area.

Research Interests

Professor Goonewardena’s research interests primarily focus on maternal and child health, reproductive health, adolescent health, and health system improvements in low-resource settings. She has a particular interest in exploring ways to improve healthcare delivery at the community level, especially in underprivileged and rural areas. Her work has frequently addressed issues such as postpartum care, antenatal care, menstrual hygiene, and breastfeeding practices, aiming to provide evidence-based solutions to improve public health outcomes. In recent years, she has expanded her research to include mental health and cancer pain management, reflecting a holistic approach to healthcare that considers both physical and mental well-being. Her research is not only academically rigorous but also highly practical, often leading to recommendations that influence health policy and clinical practice in Sri Lanka.

Award and Recognition

Professor Goonewardena has been the recipient of numerous prestigious awards for her contributions to public health and research. In 2002, she received the Sir Nicholas Attygalle Award for her research on improving intrapartum and postpartum care. She has also been recognized with multiple Best Paper and Best Oral Presentation awards at national and international conferences, including the South Asian Association of Physiologists and the Sri Lanka Medical Association. In 2015, she won the Best Poster Award at the International Research Conference of Sir John Kotelawala Defence University for her work on antenatal care knowledge. Her achievements reflect both the depth and breadth of her research, with accolades in areas ranging from adolescent health to cancer pain management. These awards underscore her role as a leading researcher in community medicine, both within Sri Lanka and internationally.

 

Publication Top Notes

  • Delay among women reporting symptoms of breast cancer
    📝 Authors: Kumari PBV, Goonewardena CSE
    📅 Year: 2011
    📚 Citation: JCCPSL, Vol 16, No 1, June 2011
  • Cancer: A hidden burden (Editorial)
    📝 Author: Goonewardena CSE
    📅 Year: 2011
    📚 Citation: JCCPSL, Vol 16, No 1, June 2011
  • Extra-Curricular Activities and Factors Associated Among School-Going Adolescents in an Urban Area of Sri Lanka
    📝 Authors: Weerasinghe IE, Gunawardana CSE, Jayatilake JAMS
    📅 Year: 2014
    📚 Citation: Global Education Review, Vol 2, No 2, February 2014, 72-82
  • Vaginal discharge: Women’s health-seeking behavior and cultural practices
    📝 Authors: Ilankoon IMPS, Goonewardena CSE, Perera PPR, Fernandopulle RC
    📅 Year: 2015
    📚 Citation: International Journal of Current Research, Vol 7, Issue 6, June 2015
  • Quality of life of caregivers and impact on the nuclear family of children with leukaemia in the National Cancer Institute of Sri Lanka
    📝 Authors: Pathirana TI, Goonewardena CSE, Wijesiriwardane I
    📅 Year: 2015
    📚 Citation: Journal of the Postgraduate Institute of Medicine, Vol 2: E18, 1-5
  • Factors associated with growth faltering in Sri Lankan infants: A case-control study in selected child welfare clinics in Sri Lanka
    📝 Authors: Nevinda de Silva, Wijerathna K, Kahatapitiya S, Silva P, Perera R, Goonewardena S
    📅 Year: 2015
    📚 Citation: Journal of the Postgraduate Institute of Medicine, Vol 2: E19, 1-9
  • Public Health Midwives’ role in health education regarding vaginal discharge: A Cross-Sectional Descriptive Study
    📝 Authors: Ilankoon IMPS, Goonewardena CSE, Fernandopulle RC, Perera PPR
    📅 Year: 2016
    📚 Citation: International Journal of Scientific Research and Management, Vol 4, Issue 06, 4303-4310
  • Pre-hospital care received by injured children less than five years admitted to the Lady Ridgeway Hospital for children, Colombo
    📝 Authors: Gunawardhana YAGK, Goonewardena CSE
    📅 Year: 2015
    📚 Citation: Journal of the College of Community Physicians of Sri Lanka, Vol 21, No 1
  • Self-medication practices and misuse of medicine among mothers of young children attending a teaching hospital in Sri Lanka
    📝 Authors: De Silva BP, Hussain FH, Ginige G, Kulathunge A, Kannangara H, Goonawardane S, Gamage M
    📅 Year: 2017
    📚 Citation: Sri Lanka Journal of Child Health, 46
  • Assessment of knowledge on the disease, its complications, and management strategies among hypertensive patients attending medical clinics at Teaching Hospital, Batticaloa, Sri Lanka
    📝 Authors: Kisokanth G, Illankoon IMPS, Arulanandem K, Goonewardena CSE, Sundaresan KT, Joseph J
    📅 Year: 2016
    📚 Citation: Journal of the Postgraduate Institute of Medicine, Vol 3: E30, 1-1

Chun Liu | Earth and Planetary Sciences | Best Scholar Award

Assoc Prof Dr. Chun Liu | Earth and Planetary Sciences | Best Scholar Award

Assoc Prof Dr. Chun Liu, Jinan University, China

Chun Liu is a distinguished researcher in Earth and Planetary Sciences, recognized for her significant contributions to the understanding of planetary geology and geophysics. Currently pursuing her PhD at [insert university name], her research focuses on [insert specific research area or project]. Píng has authored several influential papers published in top-tier journals, highlighting her innovative methodologies and insights into planetary processes. With a strong commitment to advancing scientific knowledge, she actively engages in community outreach and mentorship programs, inspiring the next generation of Earth scientists. Her dedication and impactful research have earned her the prestigious Best Scholar Award.

Profile:

 

Education

Chun Liu holds a Doctoral Degree in Environmental Science and Engineering from Hunan University, where she conducted her research at the State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau, under the supervision of Prof. Zhongwu Li. She completed her doctoral studies in June 2019. Chun also served as a visiting scholar at the University of California, Merced, from November 2017 to December 2018, collaborating with Prof. Asmeret Asefaw Berhe. Prior to her doctorate, she earned a Master’s Degree in Hydrology and Water Resources Science from Hunan Normal University, working under the guidance of Profs. Dianqing Lv and Hongsong Chen. Chun began her academic journey with a Bachelor’s Degree in Water Resources and Hydroelectric Engineering from Hunan Agricultural University, mentored by Prof. Bangsong Yao. Her diverse educational background has equipped her with a strong foundation in environmental science and water resource management.

Professional Experience

Chun Liu is currently an Associate Professor at the Institute of Groundwater and Earth Sciences at Jinan University in Guangzhou, Guangdong, China, a position she has held since September 2019. In this role, she focuses on advancing research in groundwater management and environmental science, contributing to both academic knowledge and practical applications in the field. Her expertise and dedication to teaching have made her a valuable asset to the institute, where she engages in mentoring students and collaborating on interdisciplinary research projects aimed at addressing critical environmental challenges.

Research Interests

Chun Liu’s research interests encompass a diverse range of topics within environmental science, with a particular focus on soil erosion and carbon cycling. She investigates soil biogeochemistry and karst hydrology, exploring the complex interactions between these systems and climate change. Additionally, Chun is dedicated to studying groundwater pollution and prevention strategies. Her work involves applying various tracers, such as isotopes, spectroscopy, and biomarkers, to identify eroded organic matter, as well as utilizing models to quantify this eroded material. Through her research, she aims to enhance understanding of these critical processes and develop effective solutions for environmental management.

Award and Recognition

Chun Liu has received numerous honors and awards throughout her academic career, underscoring her exceptional contributions to the field of environmental science. In 2018, she was recognized with an ESI Hot Paper distinction, placing her in the top 1% for agricultural science, as well as achieving a Highly Cited Paper status. Additionally, her master’s thesis was awarded Excellent Master’s Thesis in Hunan Province in 2017. Chun was also honored as an Excellent Doctoral Candidate and Excellent Doctoral Graduate at Hunan University in 2018. Earlier in her career, she was recognized as an Advanced Individual in a university program aimed at enhancing social practice activities among officials in 2012. These accolades reflect her dedication to research and academic excellence.

 

Publication Top Notes

Liu, C., Wang, D., Dong, F. F., Hu, B. X., Li, Z. W., Huang, B. (2021). Modeling organic matter sources of sediment fluxes in eroding landscapes: Review, key challenges, and new perspectives. Geoderma, 383, 114704.

Lan, G. Y., Liu, C., Wang, H., Cao, J. H., Tang, W., Li, Q., Hu, B. X. (2021). Linking soil redistribution to soil organic carbon using 210Pb ex along different complex toposequences in a karst region, southwest China. Catena, 202, 105239.

Wang, D., Huang, X. D., Qiao, N., Geng, Q. L., Liu, Y. Z., Song, H. Q., Yang, Z. L., Liu, C.* (2020). Effects of mowing and fertilization on soil quality in a semiarid grassland of North China. Land Degradation & Development, 32, 1656-1666.

Liu, C., Li, Z. W.*, Berhe, A. A., Hu, B. X. (2020). The isotopes and biomarker approaches for identifying eroded organic matter sources in sediments: A review. Advances in Agronomy, 162, 257-303.

Liu, C., Li, Z. W.*, Hu, B. X., Yan, J., Xiao, H. B. (2020). Identifying eroded organic matter sources in sediments at a fluvial system using multiple tracers on the Loess Plateau of China. Catena, 193, 104623.

Li, Z. W., Peng, H., Xie, B. G., Liu, C., Nie, X. D., Wang, D. Y., Huang, M., Xiao, H. B., Shi, L., Zhang, X. Q., Jiang, J. Y. (2020). Dissolved organic matter in surface runoff in the Loess Plateau of China: the role of rainfall events and land-use. Hydrological Processes, 34, 1446-1459.

Liu, C., Li, Z. W.*, Berhe, A. A., Zeng, G. M., Xiao, H. B., Liu, L., Wang, D. Y., Peng, H. (2019). Chemical characterization and source identification of organic matter in eroded sediments: role of land use and erosion intensity. Chemical Geology, 506, 97-112.

Liu, C., Li, Z. W.*, Berhe, A. A., Xiao, H. B., Liu, L., Wang, D. Y., Peng, H., Zeng, G. M. (2019). Characterizing eroded dissolved organic matter in a loess hilly catchment using fluorescence EEM-PARAFAC and UV-Visible absorption: Insights from source identification and carbon cycling. Geoderma, 334, 37-48. (ESI 1% Highly Cited Paper).

Liu, C., Li, Z. W., Chang, X. F., He, J. J., Nie, X. D., Liu, L., Xiao, H. B., Wang, D. Y., Peng, H., Zeng, G. M. (2018). Soil carbon and nitrogen sources and redistribution as affected by erosion and deposition processes: A case study in a loess hilly-gully catchment, China. Agriculture, Ecosystems & Environment, 253, 11-22.

Liu, C., Li, Z. W.*, Chang, X. F., Nie, X. D., Liu, L., Xiao, H. B., Wang, D. Y., Peng, H., Zeng, G. M. (2018). Apportioning source of erosion-induced organic matter in the hilly-gully region of the Loess Plateau in China: Insight from lipid biomarker and isotopic signature analysis. Science of the Total Environment, 621, 1310-1319.

Farouk Oladoja | Pharmacology | Best Researcher Award

Dr. Farouk Oladoja | Pharmacology | Best Researcher Award

Lecturer, Olabisi Onabanjo University , Nigeria

Dr. Farouk Adedeji Oladoja is a Lecturer II at Olabisi Onabanjo University’s Department of Pharmacology and Toxicology. He holds a B.Pharm from Olabisi Onabanjo University and an M.Sc in Pharmacology, Therapeutics, and Toxicology from the University of Lagos. He is currently pursuing a PhD in Pharmacology. Dr. Oladoja’s research focuses on pharmacological activities of natural compounds, including antidiabetic and antioxidant properties, and toxicological studies. He has worked on various projects such as the effects of Datura stramonium and the evaluation of SARS-CoV-2 variants. Dr. Oladoja has co-authored multiple peer-reviewed articles and contributed to the understanding of alternative medicine and phytomedicine in Africa. His professional experience includes teaching pharmacology to medical, pharmacy, and nursing students. His excellence has been recognized through awards, including the 2021 first prize for poster presentation at the University of Lagos. Dr. Oladoja continues to contribute significantly to pharmacology research and education.

Profile:

Education

Dr. Farouk Adedeji Oladoja is an accomplished scholar with a strong educational background in Pharmacology and related fields. He earned his Bachelor of Pharmacy (B.Pharm Hons) from Olabisi Onabanjo University, Ago-Iwoye, in 2014. Driven by his passion for advanced knowledge, he pursued a Master of Science (M.Sc) in Pharmacology, Therapeutics, and Toxicology at the University of Lagos, Akoka, completing the program in 2019. In addition to his pharmaceutical education, Dr. Oladoja has diversified his skill set by obtaining professional certifications. He became an Associate of the Institute of Chartered Accountants of Nigeria (ICAN) in 2018, enhancing his expertise in financial management. He also holds memberships in the Chartered Institute of Materials and Warehousing Management (ACIWM) and the Chartered Institute of Supply Chain Management (ACISM), further broadening his interdisciplinary knowledge. Currently, Dr. Oladoja is awaiting admission for his PhD in Pharmacology at the University of Lagos, Nigeria.

Professional Experience

Dr. Farouk Adedeji Oladoja has a solid foundation in Pharmacology and Toxicology, having served as a Lecturer at Olabisi Onabanjo University (OOU) since January 2021. With over two years of teaching experience, he has been actively involved in instructing undergraduate students in pharmacology across various programs, including Medicine, Nursing, and Pharmacy. His previous roles span clinical and community pharmacy positions, notably at HealthPlus Pharmacy, Olabisi Onabanjo University Teaching Hospital, and Mapic Pharmacy. In his current role, Dr. Oladoja teaches core pharmacology courses, supervises undergraduate projects, and contributes to curriculum development. His research interests include antidiabetic, antioxidant, and neuropharmacological studies, with a particular focus on African phytomedicine. He has authored numerous peer-reviewed papers and collaborated on projects ranging from toxicology studies to the phylogenetic analysis of SARS-CoV-2 variants in Nigeria. Dr. Oladoja’s academic and research contributions reflect his dedication to advancing pharmacological knowledge and practice.

Research Skills

Dr. Oladoja Farouk Adedeji possesses extensive research skills, particularly in pharmacology, toxicology, and natural products. His research expertise spans drug discovery, pharmacokinetics, pharmacodynamics, and the therapeutic properties of medicinal plants. Dr. Oladoja has conducted in-depth studies on the antidiabetic, antioxidant, and neuropharmacological properties of various plant extracts, contributing to scientific knowledge on alternative medicine and toxicology. His work also extends to toxicological assessments, having investigated the acute and sub-acute toxicity of herbal extracts. He is skilled in data collection, manuscript writing, and experimental design, as demonstrated in his numerous publications on plant-based treatments and toxicology. His involvement in advanced biochemical analysis, including antioxidant and anti-inflammatory assays, underscores his proficiency in laboratory techniques and research methodologies. Dr. Oladoja is committed to exploring the pharmacological potential of natural compounds, contributing significantly to the fields of pharmacology and toxicology.

Award and Recognition

Dr. Farouk Adedeji Oladoja has demonstrated excellence in pharmacology and toxicology, earning multiple awards and recognition throughout his career. Notably, he received the prestigious Distinguished Merit Award for Excellent Achievement in Sagamu for his contributions to community development. His academic prowess was acknowledged during his time at Olabisi Onabanjo University, where he was honored with the PANS OOU Excellence Award for being the Most Distinguished Student in 2013 and again in 2014. In 2021, Dr. Oladoja secured first place at the Annual General Meeting and Scientific Conference of the University of Lagos’ Faculty of Basic Medical Sciences for his outstanding poster presentation. These accolades reflect his dedication to research, education, and service, marking him as a leader in his field. His commitment to advancing pharmacology through research and teaching has earned him a well-deserved reputation for academic and professional excellence.

Conclusion

Dr. Oladoja has made significant contributions to the fields of pharmacology and toxicology within his short academic career. His innovative research, collaborative publications, and commitment to advancing African phytomedicine make him a strong contender for the Best Researcher Award. However, addressing his career advancement and seeking external funding would further solidify his position as an academic leader.

Publication Top Notes

  1. Title: Citrus aurantifolia (Chrism.) Swingle peel extract attenuate nephrotoxicity induced by doxorubicin
    Authors: Oyinloye, E.O.; Murtala, A.A.; Oladoja, F.A.; Kasumu, O.E.; Osipitan, L.E.
    Year: 2024
    Journal: Pharmacological Research – Modern Chinese Medicine
    Volume: 11, Article ID: 100412
  2. Title: Cajanus cajan (L) Millsp seeds extract prevents rotenone-induced motor- and non-motor features of Parkinson disease in mice: Insight into mechanisms of neuroprotection
    Authors: Olubodun-Obadun, T.G.; Ishola, I.O.; Folarin, O.R.; Olopade, J.O.; Adeyemi, O.O.
    Year: 2024
    Journal: Journal of Ethnopharmacology
    Volume: 322, Article ID: 117623
  3. Title: Bambusa vulgaris attenuates Haloperidol-induced motor deficit and non-Motor co-morbidity in rats through up-regulation of Dopamine transmission and mitigation of pro-inflammatory cytokines activities
    Authors: Murtala, A.A.; Oladapo, O.E.; Oladoja, F.A.; Olaniran, E.O.; Osonuga, O.O.
    Year: 2024
    Journal: Pharmacological Research – Modern Chinese Medicine
    Volume: 10, Article ID: 100375
  4. Title: Hypoglycemic, antidiabetic and toxicological evaluation of leaf extract of Xylopia parviflora (A. rich.) Benth
    Authors: Oladoja, F.A.; Irokosu, E.S.; Oyinloye, E.O.; Pender, G.C.; Popoola, O.A.
    Year: 2024
    Journal: Pharmacological Research – Modern Chinese Medicine
    Volume: 10, Article ID: 100358
  5. Title: Evaluation of Phytochemical constituents, Total Phenolic contents and in vitro Antioxidant Activities of Mucuna pruriens fractions leaves
    Authors: Elijah, O.O.; Murtala, A.A.; Oladoja, F.A.; Aderinola, A.A.; Kasumu, E.O.
    Year: 2023
    Journal: Journal of Phytomedicine and Therapeutics
    Volume: 22(1), pp. 1017–1034
  6. Title: Effects of glyphosate-based herbicide on gametes fertilization and four developmental stages in Clarias gariepinus
    Authors: Kale, O.E.; Adebesin, A.N.; Kale, T.F.; Wahab, M.; Ebele, C.C.
    Year: 2023
    Journal: Heliyon
    Volume: 9(4), e15048
  7. Title: Ethyl acetate fraction of Mucuna pruriens leaves mitigates diclofenac-induced hepatotoxicity via modulation of biochemical and histological parameters changes in Wistar Rats
    Authors: Oyinloye, O.; Murtala, A.; Oladoja, F.; Kasumu, E.; Iloka, P.
    Year: 2023
    Journal: Pharmacia
    Volume: 70(4), pp. 1201–1208
  8. Title: Alternative Medicine in Health Care: Is the Time not Now to Standardize African Phytomedicine to Indigenize Health Care and Create Entrepreneurial Opportunities?
    Authors: Adedeji, A.A.; Talabi, I.E.; Oladoja, F.
    Year: 2023
    Book: Medical Entrepreneurship: Trends and Prospects in the Digital Age, pp. 259–273
  9. Title: Antibiotic utilization study in a teaching hospital in Nigeria
    Authors: Sekoni, K.F.; Oreagba, I.A.; Oladoja, F.A.
    Year: 2022
    Journal: JAC-Antimicrobial Resistance
    Volume: 4(5), dlac093
  10. Title: Datura stramonium abrogates depression- and anxiety-like disorders in mice: possible involvement of monoaminergic pathways in its antidepressant activity
    Authors: Akanji, M.A.; Elijah, O.O.; Oyedolapo, A.A.; Olatundun, S.O.; Edatomolaosi, O.L.
    Year: 2022
    Journal: Drug Metabolism and Personalized Therapy
    Volume: 37(3), pp. 305–314

 

Soha Ismai | Pharmacology, Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

Assist Prof Dr. Soha Ismai | Pharmacology, Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

Assistant Professor, EDA, Egypt

With a solid foundation in pharmacy, including a Bachelor’s, Master’s, and PhD from Cairo University, and a position as Associate Professor, this individual demonstrates exceptional expertise. Their diverse professional experience spans quality control, management, and academic roles, showcasing their leadership and practical knowledge in the pharmaceutical field. Their prolific research output includes numerous publications on advanced drug delivery systems and nanotechnology, reflecting significant contributions to pharmaceutical sciences. Active participation in various training courses, workshops, and international conferences highlights their commitment to continuous professional development. Additionally, their multilingual skills enhance their ability to collaborate in diverse settings. Overall, their comprehensive background in education, research, and professional development, combined with their active engagement in the scientific community, makes them a highly suitable candidate for the Best Researcher Award.

Education

The candidate has a robust educational background that serves as the foundation of their expertise in the field of pharmaceutical sciences. They earned a Bachelor of Pharmacy degree from Cairo University in 1996, graduating with honors, which set the stage for their academic and professional journey. Their pursuit of advanced knowledge led them to complete a Master’s degree in Pharmaceutics in 2007 and later a PhD in 2011, both from the same esteemed institution. This rigorous academic training has equipped them with in-depth knowledge of pharmaceutics, drug formulation, and pharmaceutical analysis. In 2019, they further solidified their academic credentials by attaining the position of Associate Professor, demonstrating their commitment to education, research, and mentorship. Their continuous academic progression reflects a strong commitment to excellence and a desire to contribute significantly to the pharmaceutical sciences, positioning them as a thought leader in their field and a prime candidate for the Best Researcher Award.

Profesional Experience

The candidate has an extensive professional background in the pharmaceutical sector, beginning their career as a QC analyst for raw materials at NODCAR from 1996 to 1999. They then transitioned to academia as a teaching assistant at the Faculty of Pharmacy, October University, in 1999. Between 2000 and 2012, they worked as a QC analyst specializing in physical properties before moving into management roles, including quality manager and deputy lab manager. From 2016 to 2021, they served as a technical manager, demonstrating their expertise in overseeing laboratory operations and maintaining quality standards. Their role expanded further as they joined several committees, contributing to updating pharmaceutical guidelines and developing the Egyptian pharmacopeia. In 2021, they became the lab manager of the physicochemical lab at the Egyptian Drug Authority (EDA), where they continue to lead and innovate in quality control and research.

Research Skill

The candidate possesses exceptional research skills, demonstrated through a prolific publication record in high-impact journals and extensive experience in developing innovative pharmaceutical formulations. They have expertise in designing and conducting complex experimental studies, including the use of advanced methodologies like Box–Behnken design for optimization and in vivo evaluations. Their research work spans various domains, including nanotechnology, ocular drug delivery, and gastroretentive systems, showcasing versatility and a strong ability to adapt to emerging scientific trends. Additionally, their role in supervising master’s and PhD theses highlights their leadership in guiding future researchers. The candidate is also well-versed in utilizing statistical analysis tools and quality-by-design approaches, which are critical for ensuring the rigor and reliability of research findings. Their ability to translate research into practical applications, coupled with active participation in committees that shape pharmaceutical guidelines, underscores a profound impact on both academic and industry standards in the pharmaceutical sciences.

Awards And Recoginition

The individual has received multiple accolades throughout their career, reflecting their outstanding contributions to the field of pharmaceutical sciences. Their expertise in pharmaceutics and dedication to research have been recognized by esteemed institutions and professional bodies. Notably, they have been honored for their innovative work in drug delivery systems and quality management, which have had a significant impact on the pharmaceutical industry. They have been a valuable member of committees responsible for updating pharmaceutical guidelines and establishing national standards, further highlighting their influence and leadership in the field. Additionally, their research publications in renowned international journals have been widely cited, earning them recognition among peers as a leading researcher. Their participation in prestigious conferences and workshops, both as a presenter and a participant, underscores their commitment to continuous learning and sharing knowledge. These recognitions affirm their position as a distinguished professional dedicated to advancing pharmaceutical science and improving healthcare outcomes.

Conclution

The individual’s blend of academic excellence, practical experience, prolific research output, and continuous professional growth makes them a highly suitable candidate for the Best Researcher Award. Their achievements reflect their dedication to advancing pharmaceutical science and their impact on the field.

Publication Top Notes

  1. Enhanced wound healing activity of naturally derived Lagenaria siceraria seed oil binary nanoethosomal gel: formulation, characterization, in vitro/in vivo efficiency
    • Authors: Nagham H. Kamal, Fatema R. Saber, Abeer Salama, Dalia M. N. Abouhussein, Soha Ismail, Hala M. El-Hefnawy, Meselhy R. Meselhy
    • Year: 2024
    • Citation: Kamal NH, Saber FR, Salama A, Abouhussein DMN, Ismail S, El-Hefnawy HM, Meselhy MR. Enhanced wound healing activity of naturally derived Lagenaria siceraria seed oil binary nanoethosomal gel: formulation, characterization, in vitro/in vivo efficiency. Future Journal of Pharmaceutical Sciences. 2024 Aug 19. doi:10.1186/s43094-024-00678-2.
  2. Mucoadhesive Chitosan Composite Sponge as a Carrier for β-Sitosterol Cubosomes for Thermal Burn Treatment
    • Authors: Abeer Khattab, Soha Ismail, Areeg M. Abd-Elrazek
    • Year: 2024
    • Citation: Khattab A, Ismail S, Abd-Elrazek AM. Mucoadhesive Chitosan Composite Sponge as a Carrier for β-Sitosterol Cubosomes for Thermal Burn Treatment. AAPS PharmSciTech. 2024 Jun 27. doi:10.1208/s12249-024-02852-4.
  3. Optimization of topical curcumin spanlastics for melanoma treatment
    • Authors: Soha Ismail, Doaa Garhy, Howida K. Ibrahim
    • Year: 2023
    • Citation: Ismail S, Garhy D, Ibrahim HK. Optimization of topical curcumin spanlastics for melanoma treatment. Pharmaceutical Development and Technology. 2023 May 28. doi:10.1080/10837450.2023.2204926.
  4. Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box–Behnken design and in vivo evaluation
    • Authors: Marwa H. Shukr, Soha Ismail, Ghada G. El-Hossary, Amany H. El-Shazly
    • Year: 2022
    • Citation: Shukr MH, Ismail S, El-Hossary GG, El-Shazly AH. Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box–Behnken design and in vivo evaluation. Journal of Liposome Research. 2022 Oct 2. doi:10.1080/08982104.2022.2025828.
  5. Alfuzosin hydrochloride-loaded low-density gastroretentive sponges: development, in vitro characterization and gastroretentive monitoring in healthy volunteers via MRI
    • Authors: Marwa Farrag Abd El-Aziz, Soha Ismail, Mina Ibrahim Tadros, Mohamed Ahmed Elnabarawi
    • Year: 2020
    • Citation: Abd El-Aziz MF, Ismail S, Tadros MI, Elnabarawi MA. Alfuzosin hydrochloride-loaded low-density gastroretentive sponges: development, in vitro characterization and gastroretentive monitoring in healthy volunteers via MRI. Pharmaceutical Development and Technology. 2020 May 27. doi:10.1080/10837450.2020.1720235.
  6. Development and optimization of ezetimibe nanoparticles with improved antihyperlipidemic activity
    • Authors: Marwa H. Shukr, Soha Ismail, Samya Mahmoud Ahmed
    • Year: 2019
    • Citation: Shukr MH, Ismail S, Ahmed SM. Development and optimization of ezetimibe nanoparticles with improved antihyperlipidemic activity. Journal of Drug Delivery Science and Technology. 2019 Feb. doi:10.1016/j.jddst.2018.12.001.
  7. Butoconazole nitrate vaginal sponge: Drug release and antifungal efficacy
    • Authors: Dalia S. Shaker, Soha Ismail, Selwan Hamed, Eman M. El-Shishtawy
    • Year: 2018
    • Citation: Shaker DS, Ismail S, Hamed S, El-Shishtawy EM. Butoconazole nitrate vaginal sponge: Drug release and antifungal efficacy. Journal of Drug Delivery Science and Technology. 2018 Dec. doi:10.1016/j.jddst.2018.09